Should you buy NOV right now? Stockgaide's AI rates NOV as
HOLD, with a technical score of
70/100 at a last price of $20.23.
The 50-day average is above the 200-day average, and RSI sits at 53.1.
Wall Street's consensus rating is 2.46/5.
Full AI analysis for NOV
Strategic Conclusion
Recommendation: Hold
Why? The stock shows a bullish medium-term trend (price above both 50-day and 200-day SMAs) and a strong technical score of 70, but momentum is mixed — MACD is below its signal line and RSI is neutral. Valuation is stretched with a P/E of 77.45, which limits upside potential despite the positive price action. Analyst consensus is moderately positive but not overwhelmingly bullish.
Ideal profile: A balanced investor comfortable with holding through short-term volatility while waiting for clearer momentum or a better entry point.
Price range: Current price $20.25 is near the 52-week high of $21.67. Support at $19.58 (SMA50) and $18.75 (SMA200). Resistance at $21.67. A pullback toward $19.50–$19.80 would offer a more attractive entry.
Practical action: Hold existing positions. Do not add at current levels. If price breaks above $21.67 with volume, consider adding. If it falls below $18.75, reassess the thesis.
1. Recent Price & Momentum
Current price $20.25 is 8.5% above the 52-week low ($12.29) and 6.5% below the 52-week high ($21.67). The stock is in the upper third of its 52-week range, indicating a strong recovery but not yet at overbought extremes.
Momentum is mixed: RSI at 53.1 is neutral (no overbought/oversold signal), while MACD is below its signal line (short-term bearish divergence). The price is above both SMAs, confirming a longer-term uptrend, but the recent MACD crossover suggests a possible consolidation or pullback.
2. Valuation (P/E)
P/E (TTM) is 77.45, which is significantly higher than the typical energy/oilfield services sector average (usually 15–25). This implies the market is pricing in strong future earnings growth.
Given the high multiple, the stock already reflects optimistic expectations. Any earnings miss or macro headwind could trigger a de-rating. The current price does not offer a margin of safety for value investors.
3. Technical Analysis
SMA50 ($19.58) > SMA200 ($18.75) — golden cross configuration, confirming a medium-term uptrend.
RSI (14) = 53.1 — neutral, no clear directional bias.
MACD (12,26,9) = 0.1456, Signal = 0.2491, Histogram = -0.1035 — MACD line below signal, histogram negative, indicating bearish momentum in the short term.
Technical Score: 70/100 (Buy) — driven by the golden cross and price above SMAs, but the MACD divergence and neutral RSI temper the bullish signal.
4. Analyst Consensus
Mean rating 2.46 (where 1 = Strong Buy, 5 = Sell) — translates to Moderate Buy.
Distribution:11 Buy, 11 Hold, 2 Sell — a balanced but not overwhelmingly bullish view. Analysts see value but are cautious on near-term upside.
This consensus aligns with the technical score (both lean positive) but diverges from the valuation (high P/E suggests limited upside). The mixed signals support a Hold stance.
Technical signal details
Rule-based read from price and momentum indicators only — the score behind the AI's recommendation above. Technical score: 70/100 (BUY).
50-day moving average is above the 200-day — medium-term uptrend (golden-cross territory).
MACD is below its signal line — bearish momentum.
RSI at 53.09 — neutral momentum.
Wall Street consensus rating of 2.46 — moderately positive.
Stockgaide's AI currently rates NOV as HOLD, with a technical score of 70 out of 100 at a last price of $20.23. This is educational content, not investment advice.
Is NOV in an uptrend?
NOV's 50-day moving average (19.58) is above its 200-day moving average (18.75), which points to a medium-term uptrend.
What is NOV's RSI today?
NOV has a 14-day RSI of 53.1, which places it in neutral territory (above 70 is overbought, below 30 is oversold).
What do analysts say about NOV?
Wall Street analysts covering NOV have a consensus rating of 2.46 out of 5 (1 = Strong Buy), meaning they are moderately positive — 11 Buy · 11 Hold · 2 Sell.
Where is NOV trading in its 52-week range?
NOV last traded at $20.23, against a 52-week range of $12.29 to $21.67 — about 85% of the way up that range.
Get the full AI analysis of NOV
Price targets, fundamentals deep-dive and an AI-written report — free, no signup.